Results 71 to 80 of about 29,657 (272)

First identification of multidrug-resistant Acinetobacter bereziniae isolates harboring blaNDM-1 from hospitals in South China

Heliyon, 2023
This study is a first report on the identification of multidrug-resistant (MDR) Acinetobacter bereziniae among non-baumannii acinetobacters that had previously escaped automated laboratory detection, and characterize their clinical courses of infection ...
Xiao-Mei Mo, Qing Pan, Harald Seifert, Xi-Wen Xing, Jing Yuan, Zi-Yuan Zhou, Xing-Yu Luo, Hou-Ming Liu, Yong-Li Xie, Liu-Qing Yang, Xiao-Bing Hong, Paul G. Higgins, Nai-Kei Wong   +12 more
doaj   +1 more source

Genotyping of carbapenem resistant Acinetobacter baumannii isolated from Egyptian patients [PDF]

, 2022
Heba Ahmed Mohamed, Gamal Fadl Mahmoud Gad, Mona Fattouh Mohamed, Hend Harby Ahmed, Ameer Effat Elfarash, Nahed Fahmy   +5 more
openalex   +1 more source

OXA-carbapenemases present in clinical acinetobacter baumannii-calcoaceticus complex isolates from patients in kurdistan region, Iraq [PDF]

, 2016
In addition to intrinsic resistance in Acinetobacter baumannii, many different types of acquired resistance mechanisms have been reported, including the presence of VIM and IMP metallo β-lactamases and also of blaOXA-23-like and blaOXA-58-like enzymes ...
Alnakshabandi, A.A., Dlnya, A. (Asad), Fatah, M.H., Ganjo, A.R. (Aryann R.), Goessens, W.H.F. (Wil), Hammerum, A.M. (Anette M.), Kok, D.J. (Dik J.), Kreft, D. (Deborah), Maghdid, D.M. (Delshad), Mansoor, I.Y. (Isam Y.), Ng, K. (Kim), Severin, J.A. (Juliëtte), Verbrugh, H.A. (Henri)   +12 more
core   +4 more sources

Safety and efficacy of colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia as part of a macro-project funded by the Seventh Framework Program of the European Commission studying off-patent antibiotics. study protocol for a randomized controlled trial [PDF]

, 2015
Background: Ventilator-associated pneumonia (VAP) is one of the most common and severe hospital-adquired infections, and multidrugresistant gram-negative bacilli (MDR-GNB) constitute the main etiology in many countries.
Clara Rosso, Fernández, DE BLASI, Roberto Alberto, George, Dimopoulos, José Garnacho, Montero, José Miguel, Cisneros, Massimo, Antonelli, The MagicBullet study, Group   +6 more
core   +1 more source

Activity of cefiderocol against high-risk clones of multidrug-resistant Enterobacterales, Acinetobacter baumannii, Pseudomonas aeruginosa and Stenotrophomonas maltophilia [PDF]

, 2020
BACKGROUND: Cefiderocol is a novel siderophore cephalosporin, developed for activity against MDR Gram-negative bacilli (MDR-GNB). OBJECTIVES: To assess the in vitro antibacterial activity of cefiderocol against a collection of MDR-GNB clinical ...
Conejo, Mª del Carmen, Delgado Valverde, María Mercedes, Fernández Cuenca, Felipe Manuel, Pascual Hernández, Álvaro, Serrano, Lara   +4 more
core   +1 more source

Detection of blaoxa-23 Gene from Carbapenem-resistant Acinetobacter Baumannii

Journal of Nepal Health Research Council, 2023
Background: Antibiotic resistance is a great concern for public health and Acinetobacter baumannii-associated infections are increasing in many parts of the world, including Nepal. However, limited data is available on the prevalence of A. baumannii harboring blaOXA-23 from Nepal.Methods: A hospital-based cross-sectional study was designed to detect ...
Laxmi Neupane, Anil Kumar Sah, Binod Rayamajhee, Anil Pokhrel, Anjana Singh   +4 more
openaire   +2 more sources

Potential of Eugenia brejoensis (Mazine) Essential Oil in Combating Multidrug‐Resistant (MDR) Acinetobacter baumannii and Pseudomonas aeruginosa

Chemistry &Biodiversity, Volume 23, Issue 1, January 2026.
ABSTRACT The genus Eugenia has a long history of use in traditional medicine for treating various conditions, including infectious diseases, gastrointestinal disorders, and skin problems. Essential oils derived from Eugenia species are known for their medicinal properties and have been studied for their antimicrobial and bioactive potential. This study
Jonathan Mandú de Araújo, Amanda Vieira de Barros, Fábio Henrique Galdino Dos Santos, Weslley Felix De Oliveira, Daniela Maria do Amaral Ferraz Navarro, Márcia Vanusa da Silva, Bruno Oliveira de Veras, John Eversong Lucena de Vasconcelos, Henrique Douglas Melo Coutinho, Maria Betânia de Melo Oliveira, Maria Tereza dos Santos Correia   +10 more
wiley   +1 more source

β-lactamase genes in carbapenem resistance Acinetobacter baumannii isolates from a Turkish university hospital

Journal of Infection in Developing Countries, 2019
Introduction: The spread of Acinetobacter baumannii, resistant to most of the available antimicrobial agents, is a serious health problem. The high rate of carbapenem resistance among Acinetobacter baumannii isolates is considered as a threat to public ...
Umut Safiye Say Coskun, Emel Caliskan, Asegul Copur Cicek, Halbay Turumtay, Cemal Sandalli   +4 more
doaj   +1 more source

Efficacy of Plant Extracts against Carbapenem Resistant Acinetobacter baumannii: A Notorious Pathogen in the Intensive Care Unit [PDF]

, 2023
Manita Paneri, Prashant Sevta, Vipul D. Yagnik   +2 more
openalex   +1 more source

First report of NDM-1-producing acinetobacter baumannii in East Africa [PDF]

, 2013
Background: The emergence of carbapenem-resistant Acinetobacter baumannii (CRAB) was observed in a Kenyan hospital from 2009 to 2010. Further investigation of the dissemination of CRAB isolates and the molecular characterization of associated resistance ...
Gunturu Revathi, L. Kristopher Siu, Po-Liang Lu, Li-Yueh Huang, Higgins, Mugnier, Olaitan, Poirel, Huang, Karah, Akers, Ma, Turton   +12 more
core   +2 more sources